Mettez-vous hors ligne avec l'application Player FM !
MIRA Pharmaceuticals, Inc. Erez Aminov, CEO
Manage episode 373264159 series 2612480
MIRA is developing a new
molecular synthetic THC analog called MIRA1a, designed for the treatment of
adult patients with anxiety and cognitive decline, typically associated with
early-stage dementia.
MIRA’s initial focus will
be a dual path: potentially winning in traditional pain and anxiety markets as
well as the marijuana analog markets with a potentially safe and effective option if approved
by the FDA.
146 episodes
Manage episode 373264159 series 2612480
MIRA is developing a new
molecular synthetic THC analog called MIRA1a, designed for the treatment of
adult patients with anxiety and cognitive decline, typically associated with
early-stage dementia.
MIRA’s initial focus will
be a dual path: potentially winning in traditional pain and anxiety markets as
well as the marijuana analog markets with a potentially safe and effective option if approved
by the FDA.
146 episodes
All episodes
×Bienvenue sur Lecteur FM!
Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.